dc.contributor
Institut Català de la Salut
dc.contributor
Grup de Recerca en Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Centro de Investigación Bioméica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ICSIII), Madrid, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Hernández Pascual, Cristina
dc.contributor.author
Simó Canonge, Rafael
dc.date.accessioned
2025-10-24T08:49:45Z
dc.date.available
2025-10-24T08:49:45Z
dc.date.issued
2024-02-02T09:55:11Z
dc.date.issued
2024-02-02T09:55:11Z
dc.identifier
Simó R, Hernández C. Topical ocular administration of DPP-IV inhibitors: a new approach for treating diabetes-induced retinal neurodegeneration. Neural Regen Res. 2024 Apr;19(4):713–4.
dc.identifier
https://hdl.handle.net/11351/10964
dc.identifier
10.4103/1673-5374.353492
dc.identifier
001064661300007
dc.identifier.uri
http://hdl.handle.net/11351/10964
dc.description.abstract
Topical ocular administration; Retinal neurodegeneration; Diabetes
dc.description.abstract
Administración ocular tópica; Neurodegeneración de la retina; Diabetes
dc.description.abstract
Administració ocular tòpica; Neurodegeneració de la retina; Diabetis
dc.description.abstract
This work was funded by grants from the Instituto de Salud Carlos III (DTS18/0163 and ICI20/00129) and co-funded by European Union.
dc.format
application/pdf
dc.publisher
Wolters Kluwer Health
dc.relation
Neural Regeneration Research;19(4)
dc.relation
https://doi.org/10.4103/1673-5374.353492
dc.rights
Attribution-NonCommercial-ShareAlike 4.0 International
dc.rights
http://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Retinopatia diabètica - Tractament
dc.subject
Enzims proteolítics - Inhibidors - Ús terapèutic
dc.subject
Farmacologia ocular
dc.subject
DISEASES::Endocrine System Diseases::Diabetes Mellitus::Diabetes Complications::Diabetic Angiopathies::Diabetic Retinopathy
dc.subject
CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protease Inhibitors::Dipeptidyl-Peptidase IV Inhibitors
dc.subject
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Drug Therapy::Drug Administration Routes::Administration, Topical::Administration, Ophthalmic
dc.subject
ENFERMEDADES::enfermedades del sistema endocrino::diabetes mellitus::complicaciones de la diabetes::angiopatías diabéticas::retinopatía diabética
dc.subject
COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos::inhibidores de proteasas::inhibidores de la dipeptidil-peptidasa IV
dc.subject
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::farmacoterapia::vías de administración de medicamentos::administración tópica::administración oftálmica
dc.title
Topical ocular administration of DPP-IV inhibitors: a new approach for treating diabetes-induced retinal neurodegeneration
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
